Back

Treatment of Refractory/Resistant CMV in HCT Recipients: Optimizing Transplant Outcomes Through Contemporary CMV Management

Treating cytomegalovirus CMV infection is especially challenging in hematopoietic cell transplant HCT recipients In this ondemand webcast learn to optimize antiviral regimens for treatmentrefractory CMV infections in postHCT settings

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.5 creditsAMA PRA Category 1 Credit™Up to 0.5 creditsNursingUp to 0.5 creditsPharmacyUp to 0.5 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • Credit · Up to 0.5 credits
  • Commercial Support
  • Released
    Feb 18, 2026
  • Last day to claim credit
    Feb 18, 2027 4 months left